AIM ImmunoTech Inc.

Basic Materials · Biological Products, (No Diagnostic Substances)

—— today

Snapshot

Market cap

—

P/E

—

Forward P/E

—

EPS (TTM)

—

Dividend yield

—

Net margin

-15861.4%

ROE

142.7%

RSI (14)

—

Beta

—

Short % of float

—

Days to cover

—

52w high

No

Peers in Biological Products, (No Diagnostic Substances)

Outlook Therapeutics, Inc. Common Stock

Revolution Medicines, Inc. Common Stock

Gilead Sciences Inc

Iovance Biotherapeutics, Inc. Common Stock

ImmunityBio, Inc. Common Stock

Bio-Techne Corp.

Build a thesis around AIM

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →